The efficacy and safety of intravenous immunoglobulin infusion in 12 h for the initial treatment of Kawasaki disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The efficacy and safety of intravenous immunoglobulin infusion in 12 h for the initial treatment of Kawasaki disease

Published:2024-09 Issue:5 Volume:65 Page:441-444
ISSN:1875-9572
Container-title:Pediatrics & Neonatology
language:en
Short-container-title:Pediatrics & Neonatology

Author:

Asano Satoshi^ORCID,Fukushima Naoya,Yamada Kenichiro

Publisher

Elsevier BV

Reference18 articles.

1. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association;McCrindle;Circulation,2017

2. Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016;Makino;Pediatr Int,2019

3. Resistance to intravenous immunoglobulin in children with Kawasaki disease;Tremoulet;J Pediatr,2008

4. Guidelines for medical treatment of acute Kawasaki disease: Report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version)

5. Clinical utility of highly purified 10% liquid intravenous immunoglobulin in Kawasaki disease;Oda;J Pediatr,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3